Future Market Insights (FMI) reports that the global stem cell therapy market was valued at USD 18.7 billion in 2025 and is projected to expand to USD 20.1 billion in 2026 and USD 45.2 billion by 2036 ...

Stem cell research recently celebrated its 60th anniversary. Although the first publications in this field appeared in the early 1960s, it took another 20 years before the first embryonic stem cells ...

“For many cell-based therapies, progress comes from connecting the right pieces at the right moment,” Klein said. “When biology, computation, and the right support come together, you can start to move ...

New findings reveal that succinate signaling through SUCNR1 acts as a protective brake in acute myeloid leukemia. Modulating ...

PrimeGen US, Inc. (“PrimeGen US" or the "Company”), a pioneering biotech company advancing innovative stem cell and exosome ...

Neural crest cells are a population of stem cells that invade the embryo in early development. They play a big role in what ...

Hematopoietic stem cells (HSCs) are the cornerstone of lifelong blood formation, arising during embryogenesis from specialised endothelial precursors in a process known as the ...

In a new study published in Nature Communications, a research team at the University of Oslo have examined how cancer cells ...

Descriptions of the embryo go back at least to the time of Aristotle, but it has only been since the late 19 th century and early 20 th century that advances in experimental approaches allowed ...

Acute myeloid leukemia (AML) is an aggressive form of blood cancer. It affects people of all ages but is most common in those over 65. Around 150 people are diagnosed with the disease each year in ...